239 related articles for article (PubMed ID: 30391232)
1. Aptazyme-mediated direct modulation of post-transcriptional sgRNA level for conditional genome editing and gene expression.
Chen H; Li Y; Du C; Li Y; Zhao J; Zheng X; Mao Q; Xia H
J Biotechnol; 2018 Dec; 288():23-29. PubMed ID: 30391232
[TBL] [Abstract][Full Text] [Related]
2. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
[TBL] [Abstract][Full Text] [Related]
3. Small molecule regulated sgRNAs enable control of genome editing in E. coli by Cas9.
Iwasaki RS; Ozdilek BA; Garst AD; Choudhury A; Batey RT
Nat Commun; 2020 Mar; 11(1):1394. PubMed ID: 32170140
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Switch regulates sgRNA activity by Cre recombination for sequential editing of two loci.
Chylinski K; Hubmann M; Hanna RE; Yanchus C; Michlits G; Uijttewaal ECH; Doench J; Schramek D; Elling U
Nat Commun; 2019 Nov; 10(1):5454. PubMed ID: 31784531
[TBL] [Abstract][Full Text] [Related]
5. Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation.
Tang W; Hu JH; Liu DR
Nat Commun; 2017 Jun; 8():15939. PubMed ID: 28656978
[TBL] [Abstract][Full Text] [Related]
6. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 with single guide RNA expression driven by small tRNA promoters showed reduced editing efficiency compared to a U6 promoter.
Wei Y; Qiu Y; Chen Y; Liu G; Zhang Y; Xu L; Ding Q
RNA; 2017 Jan; 23(1):1-5. PubMed ID: 27742910
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR/Cas9 System in Plants.
Hajiahmadi Z; Movahedi A; Wei H; Li D; Orooji Y; Ruan H; Zhuge Q
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366028
[TBL] [Abstract][Full Text] [Related]
9. Points of View on the Tools for Genome/Gene Editing.
Chuang CK; Lin WM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576035
[TBL] [Abstract][Full Text] [Related]
10. Controlling CRISPR-Cas9 with ligand-activated and ligand-deactivated sgRNAs.
Kundert K; Lucas JE; Watters KE; Fellmann C; Ng AH; Heineike BM; Fitzsimmons CM; Oakes BL; Qu J; Prasad N; Rosenberg OS; Savage DF; El-Samad H; Doudna JA; Kortemme T
Nat Commun; 2019 May; 10(1):2127. PubMed ID: 31073154
[TBL] [Abstract][Full Text] [Related]
11. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
[TBL] [Abstract][Full Text] [Related]
12. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
Najah S; Saulnier C; Pernodet JL; Bury-Moné S
BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
[TBL] [Abstract][Full Text] [Related]
13. Efficient Cas9 multiplex editing using unspaced sgRNA arrays engineering in a Potato virus X vector.
Uranga M; Aragonés V; Selma S; Vázquez-Vilar M; Orzáez D; Daròs JA
Plant J; 2021 Apr; 106(2):555-565. PubMed ID: 33484202
[TBL] [Abstract][Full Text] [Related]
14. Conditional Control of CRISPR/Cas9 Function.
Zhou W; Deiters A
Angew Chem Int Ed Engl; 2016 Apr; 55(18):5394-9. PubMed ID: 26996256
[TBL] [Abstract][Full Text] [Related]
15. Optimization Strategies for the CRISPR-Cas9 Genome-Editing System.
Vejnar CE; Moreno-Mateos MA; Cifuentes D; Bazzini AA; Giraldez AJ
Cold Spring Harb Protoc; 2016 Oct; 2016(10):. PubMed ID: 27698246
[TBL] [Abstract][Full Text] [Related]
16. Partial DNA-guided Cas9 enables genome editing with reduced off-target activity.
Yin H; Song CQ; Suresh S; Kwan SY; Wu Q; Walsh S; Ding J; Bogorad RL; Zhu LJ; Wolfe SA; Koteliansky V; Xue W; Langer R; Anderson DG
Nat Chem Biol; 2018 Mar; 14(3):311-316. PubMed ID: 29377001
[TBL] [Abstract][Full Text] [Related]
17. [Advances of Cas9/sgRNA delivery system for gene editing].
Hu X; Wang S; Yu L; Zhang X; Chen W
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3880-3889. PubMed ID: 34841792
[TBL] [Abstract][Full Text] [Related]
18. [sgRNA design for the CRISPR/Cas9 system and evaluation of its off-target effects].
Xie SS; Zhang Y; Zhang LS; Li GL; Zhao CZ; Ni P; Zhao SH
Yi Chuan; 2015 Nov; 37(11):1125-36. PubMed ID: 26582526
[TBL] [Abstract][Full Text] [Related]
19. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
Haeussler M; Concordet JP
J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
[TBL] [Abstract][Full Text] [Related]
20. In Silico Meets In Vivo: Towards Computational CRISPR-Based sgRNA Design.
Chuai GH; Wang QL; Liu Q
Trends Biotechnol; 2017 Jan; 35(1):12-21. PubMed ID: 27418421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
